Evidence map›Paper›PMID 34301052›Full record

ArticlePolymers2021

Fabrication of Drug-Eluting Polycaprolactone/poly(lactic-

Yi-Pin Chen, Tsia-Shu Lo, Yu-Ting Lin, Yu-Han Chien, Chia-Jung Lu, Shih-Jung Liu

Open access · goldAbstract read
In one paragraph

Article in Polymers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Rising role of 3D-printing in delivery of therapeutics for infectious disease.Journal of controlled release : official journal of the Controlled Release Society · 2024
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Tissue-engineered repair material for pelvic floor dysfunction.Frontiers in bioengineering and biotechnology · 2022
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yi-Pin ChenDepartment of Obstetrics and Gynecology, Keelung Chang Gung Memorial Hospital, Keelung 20401, Taiwan.
Tsia-Shu LoDepartment of Obstetrics and Gynecology, Chang Gung Memorial Hospital-Linkou, School of Medicine, Chang Gung University, Taoyuan 33305, Taiwan.
Yu-Ting LinDepartment of Mechanical Engineering, Chang Gung University, Taoyuan 33302, Taiwan.
Yu-Han ChienDepartment of Mechanical Engineering, Chang Gung University, Taoyuan 33302, Taiwan.
Chia-Jung LuDepartment of Mechanical Engineering, Chang Gung University, Taoyuan 33302, Taiwan.
Shih-Jung LiuDepartment of Mechanical Engineering, Chang Gung University, Taoyuan 33302, Taiwan.ORCID 0000-0003-2083-4865
Chang Gung University · TWKeelung Chang Gung Memorial Hospital · TW

Funding

Ministry of Science and Technology, Taiwan 109-2314-B-182A-094-MY3
6 · The paper itself

Abstract

We developed biodegradable drug-eluting prolapse mats using solution-extrusion 3D printing and coaxial electrospinning techniques. The mats were composed of polycaprolactone (PCL) mesh and lidocaine-, estradiol-, metronidazole-, and connective tissue growth factor (CTGF)-incorporated poly(lactic-

Indexed as

coaxial electrospinningnanofiberspolycaprolactonepoly(lactic-co-glycolic acid)prolapse membranesolution-extrusion 3D printing

Identifiers

PMID34301052
PMCPMC8309226
OpenAlexW3177665653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.